2,5-dimethoxy-4-bromoamphetamine has been researched along with ritanserin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D | 1 |
| Kurrasch, DM; Nichols, DE; Parker, MA | 1 |
| Done, CJ; Sharp, T | 1 |
| Braida, D; Ponzoni, L; Sala, M | 1 |
4 other study(ies) available for 2,5-dimethoxy-4-bromoamphetamine and ritanserin
| Article | Year |
|---|---|
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2004 |
The role of lipophilicity in determining binding affinity and functional activity for 5-HT2A receptor ligands.
Topics: Anthracenes; Catalysis; Hydrophobic and Hydrophilic Interactions; Ligands; Lipids; Molecular Structure; Phenethylamines; Protein Binding; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists; Serotonin Receptor Agonists | 2008 |
Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo.
Topics: Amphetamines; Animals; DOM 2,5-Dimethoxy-4-Methylamphetamine; Electrophysiology; Hippocampus; Male; Neurons; Norepinephrine; p-Chloroamphetamine; Quipazine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Ritanserin; Serotonin Receptor Agonists; Spiperone; Sulpiride | 1992 |
Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors.
Topics: Amphetamines; Animals; Behavior, Animal; Conditioning, Psychological; DOM 2,5-Dimethoxy-4-Methylamphetamine; Female; Hallucinogens; Male; N-Methyl-3,4-methylenedioxyamphetamine; Receptors, Serotonin, 5-HT2; Reinforcement, Psychology; Reward; Ritanserin; Serotonin 5-HT2 Receptor Antagonists; Serotonin Receptor Agonists; Zebrafish | 2016 |